Last updated on April 2018

Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications


Brief description of study

The primary objective of this study is to evaluate the efficacy of a single, oral dose of Baloxavir Marboxil compared with placebo by measuring the time to improvement of influenza symptoms in patients with influenza presenting within 48 hours of symptom onset.

Clinical Study Identifier: NCT02949011

Contact Investigators or Research Sites near you

Start Over

Shionogi Clinical Trials Administrator Clinical ...

Shionogi Research Site
Otsu City, Japan
0.53miles

Shionogi Clinical Trials Administrator Clinical ...

Shionogi Research Site
Kyoto, Japan
9.81miles